Cellcom Société Anonyme Statistics
Total Valuation
BVMT:CELL has a market cap or net worth of TND 6.08 million. The enterprise value is 17.75 million.
Important Dates
The next estimated earnings date is Friday, December 11, 2026.
| Earnings Date | Dec 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BVMT:CELL has 4.41 million shares outstanding.
| Current Share Class | 4.41M |
| Shares Outstanding | 4.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 6.42.
| PE Ratio | 6.42 |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | 4.87 |
| P/OCF Ratio | 3.80 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 17.61, with an EV/FCF ratio of 14.27.
| EV / Earnings | 18.70 |
| EV / Sales | 0.27 |
| EV / EBITDA | 17.61 |
| EV / EBIT | 20.40 |
| EV / FCF | 14.27 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 1.85.
| Current Ratio | 1.25 |
| Quick Ratio | 0.99 |
| Debt / Equity | 1.85 |
| Debt / EBITDA | 13.95 |
| Debt / FCF | 11.31 |
| Interest Coverage | 0.64 |
Financial Efficiency
Return on equity (ROE) is 13.36% and return on invested capital (ROIC) is 4.46%.
| Return on Equity (ROE) | 13.36% |
| Return on Assets (ROA) | 1.62% |
| Return on Invested Capital (ROIC) | 4.46% |
| Return on Capital Employed (ROCE) | 10.36% |
| Weighted Average Cost of Capital (WACC) | 6.77% |
| Revenue Per Employee | 517,719 |
| Profits Per Employee | 7,340 |
| Employee Count | 129 |
| Asset Turnover | 2.00 |
| Inventory Turnover | 8.59 |
Taxes
In the past 12 months, BVMT:CELL has paid 181,999 in taxes.
| Income Tax | 181,999 |
| Effective Tax Rate | 16.12% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVMT:CELL had revenue of TND 66.79 million and earned 946,911 in profits. Earnings per share was 0.21.
| Revenue | 66.79M |
| Gross Profit | 5.95M |
| Operating Income | 868,164 |
| Pretax Income | 1.13M |
| Net Income | 946,911 |
| EBITDA | 1.01M |
| EBIT | 868,164 |
| Earnings Per Share (EPS) | 0.21 |
Full Income Statement Balance Sheet
The company has 5.30 million in cash and 14.03 million in debt, with a net cash position of -8.74 million or -1.98 per share.
| Cash & Cash Equivalents | 5.30M |
| Total Debt | 14.03M |
| Net Cash | -8.74M |
| Net Cash Per Share | -1.98 |
| Equity (Book Value) | 7.60M |
| Book Value Per Share | 1.73 |
| Working Capital | 5.99M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 1.59 million and capital expenditures -349,873, giving a free cash flow of 1.24 million.
| Operating Cash Flow | 1.59M |
| Capital Expenditures | -349,873 |
| Depreciation & Amortization | 137,575 |
| Net Borrowing | 1.71M |
| Free Cash Flow | 1.24M |
| FCF Per Share | 0.28 |
Full Cash Flow Statement Margins
Gross margin is 8.91%, with operating and profit margins of 1.30% and 1.42%.
| Gross Margin | 8.91% |
| Operating Margin | 1.30% |
| Pretax Margin | 1.69% |
| Profit Margin | 1.42% |
| EBITDA Margin | 1.51% |
| EBIT Margin | 1.30% |
| FCF Margin | 1.86% |
Dividends & Yields
BVMT:CELL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 15.57% |
| FCF Yield | 20.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | n/a |
| Graham Formula Value | |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BVMT:CELL has an Altman Z-Score of 2.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.5 |
| Piotroski F-Score | 5 |